1
ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
Condition(s):Cocaine AbuseLast Updated:March 9, 2012Completed
ALKS-33 as an Intervention: 9 Clinical Trials
Hide Studies Not Open or Pending
2
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
Condition(s):Binge Eating DisorderLast Updated:August 23, 2011Completed
3
ALK33-001: A Study of RDC-0313 Administered to Healthy Adults
Condition(s):Alcohol DependenceLast Updated:August 22, 2011Completed
4
ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
Condition(s):Alcohol DependenceLast Updated:August 23, 2011Completed
5
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
Condition(s):Substance-Related DisordersLast Updated:January 11, 2017Completed
6
ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
Condition(s):Major Depressive DisorderLast Updated:August 23, 2011Completed
7
A Study of ALKS 3831 in Adults With Schizophrenia
Condition(s):SchizophreniaLast Updated:October 6, 2021Completed
8
A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers
Condition(s):HealthyLast Updated:September 18, 2015Completed
9
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
Condition(s):Healthy VolunteersLast Updated:December 2, 2014Completed